Skip to main content

Sio Capital Management, LLC

13F filer · CIK 0001482416
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$604MU.S. long equity reported on 13F
Positions5714 new · 30 closed
Net flow last quarter-$234MBuys minus sells
Top 10 positions weight48.4%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202657 positions
AVRAnteris Technologies Global Corp.$54.6M9.04%5.69%+3.0%Q4 2024
CORCencora, Inc.$49.1M8.13%0.09%+72.1%Q2 2018
MMSMaximus, Inc.$38.5M6.36%1.37%-7.0%Q3 2024
ALLOAllogene Therapeutics, Inc.$27.7M4.59%3.86%NewQ2 2026
GMEDGlobus Medical Inc$23.8M3.95%0.22%Not reportedQ1 2017
GSKGSK plc$22.9M3.79%0.01%+13.2%Q4 2014
TYRATyra Biosciences, Inc.$22.2M3.68%1.17%+14.8%Q1 2022
WAYWaystar Holding Corp.$19M3.15%0.48%-43.6%Q4 2025
IDYAIDEAYA Biosciences, Inc.$17.9M2.96%0.50%Not reportedQ2 2020
ORKAOruka Therapeutics, Inc.$16.9M2.79%0.29%+33.7%Q4 2025
CICigna Group$15.9M2.63%0.02%Not reportedQ2 2015
SNYSanofi$15.5M2.57%0.03%+52.0%Q4 2014
ICLRIcon PLC$15.3M2.53%0.11%-71.2%Q3 2017
VTRSViatris Inc$15.2M2.51%0.08%Not reportedQ4 2024
CCRNCross Country Healthcare Inc$14.5M2.40%3.40%Not reportedQ2 2019
RAPPRapport Therapeutics, Inc.$12.8M2.12%0.64%-16.1%Q3 2025
ABTAbbott Laboratories$11.7M1.93%0.01%-31.0%Q2 2016
CELCCelcuity Inc.$11.5M1.90%0.22%-43.2%Q3 2025
ZBHZimmer Biomet Holdings, Inc.$11.3M1.87%0.07%+109.9%Q4 2015
REGNRegeneron Pharmaceuticals, Inc.$11.2M1.86%0.02%Not reportedQ3 2019
BMYBristol Myers Squibb Co$11.1M1.85%0.01%Not reportedQ3 2015
MDTMedtronic plc$11.1M1.84%0.01%Not reportedQ2 2015
VIRVir Biotechnology, Inc.$11M1.81%0.64%-28.3%Q4 2024
SENSSenseonics Holdings, Inc.$9.05M1.50%3.01%+1275.6%Q3 2018
EYPTEyePoint, Inc.$8.91M1.47%0.73%-13.7%Q1 2026
HELPCybin Inc.$8.59M1.42%2.52%NewQ2 2026
ANIPAni Pharmaceuticals Inc$8.05M1.33%0.43%-63.4%Q4 2021
TARAProtara Therapeutics, Inc.$7.34M1.21%3.25%-2.4%Q4 2024
RLMDRelmada Therapeutics, Inc.$6.94M1.15%0.94%+4.0%Q4 2022
TNGXTango Therapeutics, Inc.$6.52M1.08%0.12%NewQ2 2026
AQSTAquestive Therapeutics, Inc.$6.18M1.02%1.18%-22.7%Q1 2025
DNTHDianthus Therapeutics, Inc.$5.78M0.96%0.11%-84.0%Q1 2025
SIONSionna Therapeutics, Inc.$5.62M0.93%0.28%-56.6%Q1 2026
OCULOcular Therapeutix, Inc$5.3M0.88%0.25%-44.3%Q2 2019
ZBIOZenas BioPharma, Inc.$5.29M0.88%0.33%-37.1%Q1 2026
DRUGBright Minds Biosciences Inc.$5.19M0.86%0.97%-14.1%Q4 2024
OKUROnKure Therapeutics, Inc.$4.92M0.81%2.67%Not reportedQ1 2026
SVRASavara Inc$3.8M0.63%0.30%+0.6%Q2 2019
PMVPPMV Pharmaceuticals, Inc.$3.53M0.58%4.93%-14.4%Q3 2020
AVAHAveanna Healthcare Holdings, Inc.$3.16M0.52%0.17%Not reportedQ2 2021
OVIDOvid Therapeutics Inc.$2.7M0.45%0.54%-19.7%Q4 2019
IMNMImmunome Inc.$2.63M0.44%0.11%-24.8%Q1 2026
ANTXAN2 Therapeutics, Inc.$2.56M0.42%1.46%-19.4%Q1 2026
SERSerina Therapeutics, Inc.$1.94M0.32%3.94%Not reportedQ1 2026
ALGSAligos Therapeutics, Inc.$1.89M0.31%5.25%Not reportedQ1 2025
IBIOiBio, Inc.$1.58M0.26%1.62%Not reportedQ4 2025
XLOXilio Therapeutics, Inc.$1.46M0.24%2.32%Not reportedQ4 2025
AORTArtivion, Inc.$1.09M0.18%0.10%Not reportedQ3 2024
BBOTBridgeBio Oncology Therapeutics, Inc.$995K0.16%0.16%Not reportedQ3 2025
TELATELA Bio, Inc.$477K0.08%1.42%Not reportedQ4 2024
Q1 2026Reported May 14, 202673 positions
MMSMaximus, Inc.$49.3M7.07%1.45%+53.7%Q3 2024
WAYWaystar Holding Corp.$39.6M5.68%0.86%+167.6%Q4 2025
ICLRIcon PLC$33.9M4.86%0.40%+140.8%Q3 2017
CORCencora, Inc.$31.7M4.55%0.05%+534.6%Q2 2018
DNTHDianthus Therapeutics, Inc.$31.1M4.45%0.68%-22.0%Q1 2025
AVRAnteris Technologies Global Corp.$29.9M4.28%5.54%+187.2%Q4 2024
CORTCorcept Therapeutics Inc$27.2M3.90%0.63%NewQ1 2026
LIVNLivaNova PLC$26.8M3.84%0.77%+30.8%Q4 2025
TYRATyra Biosciences, Inc.$23.2M3.33%1.02%+15.1%Q1 2022
CELCCelcuity Inc.$22.1M3.17%0.40%-59.4%Q3 2025
GSKGSK plc$21.3M3.05%0.01%Not reportedQ4 2014
ANIPAni Pharmaceuticals Inc$20.4M2.93%1.18%+204.3%Q4 2021
ABTAbbott Laboratories$19.2M2.75%0.01%Not reportedQ2 2016
EMBCEmbecta Corp.$16.3M2.34%3.11%Not reportedQ3 2023
ABVXAbivax S.A.$15.1M2.17%0.17%+214.9%Q4 2025
VIRVir Biotechnology, Inc.$13.4M1.93%0.93%+213.3%Q4 2024
HAEHaemonetics Corp$12.4M1.78%0.49%+138.2%Q1 2025
SIONSionna Therapeutics, Inc.$11.8M1.69%0.65%NewQ1 2026
SNYSanofi$11.5M1.66%0.02%-75.3%Q4 2014
RAPPRapport Therapeutics, Inc.$11.5M1.65%0.77%+98.0%Q3 2025
TFXTeleflex Inc$11.3M1.63%0.21%+9.1%Q3 2023
BMRNBiomarin Pharmaceutical Inc$11M1.57%0.10%-16.5%Q3 2020
CCRNCross Country Healthcare Inc$10.3M1.48%3.52%+2.8%Q2 2019
TARAProtara Therapeutics, Inc.$10.3M1.47%3.58%+14.8%Q4 2024
GPCRStructure Therapeutics Inc.$10.1M1.45%0.10%+3.8%Q4 2025
BHVNBiohaven Ltd.$9.85M1.41%0.77%-6.5%Q2 2022
MNPRMonopar Therapeutics$9.51M1.36%2.59%NewQ1 2026
EYPTEyePoint, Inc.$9.3M1.33%0.86%NewQ1 2026
CRNXCrinetics Pharmaceuticals, Inc.$9.08M1.30%0.24%+100.2%Q3 2025
EWTXEdgewise Therapeutics, Inc.$8.47M1.22%0.25%+13.3%Q2 2025
CMPSCOMPASS Pathways plc$8.33M1.19%1.12%Not reportedQ4 2023
OCULOcular Therapeutix, Inc$8.2M1.18%0.44%Not reportedQ2 2019
AQSTAquestive Therapeutics, Inc.$7.98M1.14%1.55%+93.6%Q1 2025
RLMDRelmada Therapeutics, Inc.$6.72M0.96%0.92%Not reportedQ4 2022
ORKAOruka Therapeutics, Inc.$6.5M0.93%0.26%+12.2%Q4 2025
ZBIOZenas BioPharma, Inc.$6.49M0.93%0.53%NewQ1 2026
DRUGBright Minds Biosciences Inc.$6.28M0.90%1.13%+5.1%Q4 2024
QDELQuidelOrtho Corp$5.9M0.85%0.53%NewQ1 2026
ZBHZimmer Biomet Holdings, Inc.$5.66M0.81%0.03%-83.8%Q4 2015
REPLReplimune Group, Inc.$5.51M0.79%0.87%NewQ1 2026
OGNOrganon & Co.$5.19M0.74%0.33%-74.7%Q4 2021
OKUROnKure Therapeutics, Inc.$4.47M0.64%7.89%NewQ1 2026
IRONDisc Medicine, Inc.$4.17M0.60%0.17%+13.2%Q2 2024
PMVPPMV Pharmaceuticals, Inc.$3.81M0.55%5.77%+16.7%Q3 2020
IMNMImmunome Inc.$3.61M0.52%0.15%NewQ1 2026
IARTIntegra Lifesciences Holdings Corp$3.61M0.52%0.49%Not reportedQ1 2024
SVRASavara Inc$3.35M0.48%0.30%Not reportedQ2 2019
PRQRProQR Therapeutics N.V.$3.17M0.45%1.86%-9.7%Q1 2021
SIShoulder Innovations, Inc.$3.06M0.44%1.02%-7.6%Q3 2025
OVIDOvid Therapeutics Inc.$2.78M0.40%0.75%-12.3%Q4 2019
Q4 2025Reported Feb 17, 202665 positions
CELCCelcuity Inc.$47.6M7.48%0.99%-39.4%Q3 2025
CICigna Group$47.4M7.46%0.07%Not reportedQ2 2015
SNYSanofi$47.1M7.41%0.08%+72.7%Q4 2014
MMSMaximus, Inc.$43.2M6.79%0.92%-10.3%Q3 2024
ZBHZimmer Biomet Holdings, Inc.$34.7M5.45%0.19%Not reportedQ4 2015
KVUEKenvue Inc.$25.3M3.98%0.08%+73.6%Q2 2024
OGNOrganon & Co.$24.5M3.86%1.31%Not reportedQ4 2021
ICLRIcon PLC$23.2M3.65%0.17%Not reportedQ3 2017
WAYWaystar Holding Corp.$20.1M3.16%0.32%NewQ4 2025
LIVNLivaNova PLC$19.8M3.12%0.59%NewQ4 2025
DNTHDianthus Therapeutics, Inc.$19.6M3.08%1.10%-17.9%Q1 2025
BHVNBiohaven Ltd.$14.1M2.21%0.94%Not reportedQ2 2022
GPCRStructure Therapeutics Inc.$14M2.20%0.09%NewQ4 2025
BMRNBiomarin Pharmaceutical Inc$13.8M2.18%0.12%+3.4%Q3 2020
TYRATyra Biosciences, Inc.$13.8M2.18%0.98%+2.2%Q1 2022
BTSGBrightSpring Health Services, Inc.$11.5M1.81%0.16%NewQ4 2025
CNCCentene Corp$11.3M1.78%0.06%-29.2%Q1 2021
CRLCharles River Laboratories International, Inc.$11M1.73%0.11%NewQ4 2025
TFXTeleflex Inc$10.6M1.67%0.20%+116.9%Q3 2023
AVRAnteris Technologies Global Corp.$9.35M1.47%4.51%+5.8%Q4 2024
TARAProtara Therapeutics, Inc.$9.14M1.44%3.20%Not reportedQ4 2024
CCRNCross Country Healthcare Inc$8.66M1.36%3.37%Not reportedQ2 2019
HAEHaemonetics Corp$7.42M1.17%0.20%-53.2%Q1 2025
ANIPAni Pharmaceuticals Inc$6.89M1.08%0.39%+56.6%Q4 2021
AQSTAquestive Therapeutics, Inc.$6.42M1.01%0.81%-33.7%Q1 2025
DRUGBright Minds Biosciences Inc.$6.39M1.01%1.07%-57.1%Q4 2024
EWTXEdgewise Therapeutics, Inc.$5.89M0.93%0.22%-22.7%Q2 2025
ABVXAbivax S.A.$5.82M0.91%0.05%NewQ4 2025
CRNXCrinetics Pharmaceuticals, Inc.$5.81M0.91%0.13%-28.6%Q3 2025
RAPPRapport Therapeutics, Inc.$5.62M0.88%0.39%Not reportedQ3 2025
CORCencora, Inc.$5.37M0.84%0.01%Not reportedQ2 2018
MCKMckesson Corp$5.25M0.83%0.01%Not reportedQ4 2015
IRONDisc Medicine, Inc.$4.57M0.72%0.15%-79.8%Q2 2024
PRQRProQR Therapeutics N.V.$4.37M0.69%2.05%+4.3%Q1 2021
FULCFulcrum Therapeutics, Inc.$4.32M0.68%0.57%Not reportedQ4 2020
SVRASavara Inc$3.7M0.58%0.30%-15.5%Q2 2019
ORKAOruka Therapeutics, Inc.$3.58M0.56%0.24%NewQ4 2025
VTYXVentyx Biosciences, Inc.$3.5M0.55%0.54%-53.2%Q1 2024
PMVPPMV Pharmaceuticals, Inc.$3.3M0.52%4.94%Not reportedQ3 2020
SIShoulder Innovations, Inc.$3.26M0.51%1.11%-34.9%Q3 2025
ALGSAligos Therapeutics, Inc.$3.13M0.49%5.44%Not reportedQ1 2025
VIRVir Biotechnology, Inc.$2.88M0.45%0.34%Not reportedQ4 2024
ALKSAlkermes plc.$2.67M0.42%0.06%-85.9%Q1 2020
IDYAIDEAYA Biosciences, Inc.$2.62M0.41%0.09%-39.0%Q2 2020
KYMRKymera Therapeutics, Inc.$2.51M0.39%0.04%NewQ4 2025
OVIDOvid Therapeutics Inc.$2.33M0.37%1.10%Not reportedQ4 2019
CNTXContext Therapeutics Inc.$1.97M0.31%1.46%Not reportedQ2 2024
HYPRHyperfine, Inc.$1.96M0.31%Not reportedNewQ4 2025
BBOTBridgeBio Oncology Therapeutics, Inc.$1.64M0.26%0.16%Not reportedQ3 2025
IBIOiBio, Inc.$1.43M0.22%2.46%NewQ4 2025
Q3 2025Reported Nov 13, 202551 positions
MMSMaximus, Inc.$50.9M12.89%1.02%+1.7%Q3 2024
CELCCelcuity Inc.$38.9M9.83%1.82%NewQ3 2025
SNYSanofi$26.6M6.72%0.04%+200.1%Q4 2014
DNTHDianthus Therapeutics, Inc.$22.7M5.75%1.35%+144.7%Q1 2025
ALKSAlkermes plc.$20.2M5.12%0.41%Not reportedQ1 2020
IRONDisc Medicine, Inc.$18.8M4.76%0.81%Not reportedQ2 2024
MRKMerck & Co., Inc.$14.9M3.77%0.01%+1.9%Q1 2015
HSICHenry Schein Inc$14.5M3.68%0.18%NewQ3 2025
CNCCentene Corp$13.8M3.50%0.08%+47.7%Q1 2021
KVUEKenvue Inc.$13.7M3.47%0.04%Not reportedQ2 2024
BMRNBiomarin Pharmaceutical Inc$12.2M3.09%0.12%Not reportedQ3 2020
GSKGSK plc$11.6M2.94%0.01%Not reportedQ4 2014
DRUGBright Minds Biosciences Inc.$11.6M2.93%2.50%-62.8%Q4 2024
HAEHaemonetics Corp$9.65M2.44%0.42%Not reportedQ1 2025
AQSTAquestive Therapeutics, Inc.$8.37M2.12%1.23%+58.1%Q1 2025
KALVKalVista Pharmaceuticals, Inc.$8.33M2.11%1.35%NewQ3 2025
AVRAnteris Technologies Global Corp.$7.98M2.02%4.92%-3.6%Q4 2024
CRNXCrinetics Pharmaceuticals, Inc.$7.28M1.84%0.18%NewQ3 2025
TYRATyra Biosciences, Inc.$7.2M1.82%0.97%-36.5%Q1 2022
RAPPRapport Therapeutics, Inc.$5.5M1.39%0.39%NewQ3 2025
NVCRNovoCure Ltd$5.35M1.35%0.37%NewQ3 2025
ANIPAni Pharmaceuticals Inc$5.1M1.29%0.26%-50.7%Q4 2021
EWTXEdgewise Therapeutics, Inc.$4.98M1.26%0.29%-43.1%Q2 2025
TFXTeleflex Inc$4.9M1.24%0.09%Not reportedQ3 2023
SLPSimulations Plus, Inc.$4.83M1.22%1.59%NewQ3 2025
PRQRProQR Therapeutics N.V.$4.42M1.12%1.97%Not reportedQ1 2021
SIShoulder Innovations, Inc.$4.39M1.11%1.70%NewQ3 2025
PMVPPMV Pharmaceuticals, Inc.$3.69M0.93%4.98%-29.4%Q3 2020
SEPNSepterna, Inc.$3.56M0.90%0.42%-67.6%Q4 2024
IDYAIDEAYA Biosciences, Inc.$3.38M0.86%0.14%Not reportedQ2 2020
ALGSAligos Therapeutics, Inc.$3.29M0.83%5.46%Not reportedQ1 2025
ERASErasca, Inc.$2.99M0.76%0.48%Not reportedQ1 2024
VIRVir Biotechnology, Inc.$2.73M0.69%0.34%Not reportedQ4 2024
SVRASavara Inc$2.59M0.66%0.42%Not reportedQ2 2019
VTYXVentyx Biosciences, Inc.$2.58M0.65%1.16%-36.6%Q1 2024
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp$2.1M0.53%28.32%-33.0%Q2 2025
OVIDOvid Therapeutics Inc.$1.86M0.47%2.01%-36.0%Q4 2019
BBOTBridgeBio Oncology Therapeutics, Inc.$1.51M0.38%0.16%NewQ3 2025
CNTXContext Therapeutics Inc.$1.3M0.33%1.46%Not reportedQ2 2024
SENSSenseonics Holdings, Inc.$1.01M0.26%5.67%-52.3%Q3 2018
TELATELA Bio, Inc.$948K0.24%1.58%Not reportedQ4 2024
AVTXAvalo Therapeutics, Inc.$917K0.23%0.40%Not reportedQ1 2024
FHTXFoghorn Therapeutics Inc.$601K0.15%0.22%Not reportedQ4 2023
MODDModular Medical, Inc.$550K0.14%1.28%Not reportedQ2 2022
NYXHNyxoah SA$234K0.06%0.14%Not reportedQ3 2021
BOLDBoundless Bio, Inc.$201K0.05%0.73%Not reportedQ1 2024
APREAprea Therapeutics, Inc.$166K0.04%1.88%-59.8%Q1 2023
TERNTerns Pharmaceuticals, Inc.$75.9K0.02%0.01%Not reportedQ3 2024
NXTCNextCure, Inc.$64.1K0.02%0.41%0.0%Q4 2021
RCKTWRocket Pharmaceuticals, Inc.$14.4K0.00%Not reportedNot reportedQ1 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.